|
|
Volumn 9, Issue 2, 2010, Pages 94-
|
|
Deal watch: dipping into Incyte's JAK-pot.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
INCB018424;
JAK1 PROTEIN, HUMAN;
JAK2 PROTEIN, HUMAN;
JANUS KINASE 1;
JANUS KINASE 2;
PROTEIN KINASE INHIBITOR;
PYRAZOLE DERIVATIVE;
DRUG ANTAGONISM;
DRUG DELIVERY SYSTEM;
DRUG INDUSTRY;
ECONOMICS;
HUMAN;
NOTE;
PATHOPHYSIOLOGY;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
RHEUMATOID ARTHRITIS;
ARTHRITIS, RHEUMATOID;
CLINICAL TRIALS, PHASE II AS TOPIC;
CLINICAL TRIALS, PHASE III AS TOPIC;
DRUG DELIVERY SYSTEMS;
DRUG INDUSTRY;
HUMANS;
JANUS KINASE 1;
JANUS KINASE 2;
PROTEIN KINASE INHIBITORS;
PYRAZOLES;
|
|
EID: 77449146972
PISSN: None
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3113 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|